• Medicine
  • birželio 9 d.
  • FDA to approve Camurus' Oclaiz
    2
  • birželio 17 d.
  • FDA to approve GSK & Spero Therapeutics' Tebipenem HBr
    2
  • birželio 18 d.
  • FDA to approve Arcalyst technology transfer
    2
  • FDA to approve Merck's Welireg + Keytruda or Keytruda Qlex
    2
  • birželio 28 d.
  • FDA to approve Unicycive's Oxylanthanum carbonate
    2
  • birželio 29 d.
  • FDA to approve Ionis' Olezarsen
  • FDA to approve Viridian Therapeutics' Veligrotug
    2
  • gruodžio 30 d.
  • CDC to issue Level 4 warning by December 31
    2
  • FDA approves Retatrutide this year?
    2

mp